Primary Site >> Biliary tract Cancer
Gene >> CD44
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Expression of CD44 in human hepatocellular carcinoma cell lines. PMID: 7537711 Ref: [Expression of CD44 isoforms in normal human liver and also in regenerative and neoplastic liver changes]. PMID: 8600679 |
Ref: Expression of cell adhesion molecule CD44 in primary tumors of the liver: an immunohistochemical study. PMID: 9062875 |
Ref: Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study. PMID: 9537436 |
Ref: Lack of CD44 variant 6 expression in advanced extrahepatic bile duct/ampullary carcinoma. PMID: 10547541 |
Ref: Expression of variant CD44 containing variant exon v8-10 in gallbladder cancer. PMID: 10767365 |
Ref: CD44 variant overexpression in gallbladder carcinoma associated with tumor dedifferentiation. PMID: 11180088 Ref: [CD44 (HCAM) expression in subserous gallbladder carcinoma]. PMID: 11552440 |
Ref: Immunohistochemical Study for CD44v6 in Hepatocellular Carcinoma and Cholangiocarcinoma. PMID: 26680859 |
Ref: Anatomic and molecular pathology of intrahepatic cholangiocarcinoma. PMID: 14598145 |
Ref: Immunohistochemical study of microvessel density, CD44 (standard form), p53 protein and c-erbB2 in gallbladder carcinoma. PMID: 15209630 |
Ref: Significance of PML and p53 protein as molecular prognostic markers of gallbladder carcinomas. PMID: 18158568 |
Ref: Prognostic significance of CD44s expression in biliary tract cancers. PMID: 18214619 Ref: Gene expression profiles in gallbladder cancer: the close genetic similarity seen for early and advanced gallbladder cancers may explain the poor prognosis. PMID: 18497548 |
Ref: Identification of hepatic stem/progenitor cells in canine hepatocellular and cholangiocellular carcinoma. PMID: 20579324 Ref: CD44+ CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma. PMID: 20948317 |
Ref: Isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties. PMID: 20232394 Ref: Preliminary screening and identification of stem cell-like sphere clones in a gallbladder cancer cell line GBC-SD. PMID: 21462380 Ref: Silencing of CD44 by siRNA suppressed invasion, migration and adhesion to matrix, but not secretion of MMPs, of cholangiocarcinoma cells. PMID: 21833756 Ref: Significance of CD44s and CD44v6 expression in pancreaticobiliary maljunction. PMID: 22024057 |
Ref: Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater. PMID: 22130902 Ref: Association of stem cell marker expression pattern and survival in human biliary tract cancer. PMID: 22614781 Ref: Recent advances in cancer stem cell research for cholangiocarcinoma. PMID: 22907641 Ref: Aberrant expression of CD44 in bile duct cancer correlates with poor prognosis. PMID: 23480770 |
Ref: Clinical significances of cancer stem cells markers in patients with intrahepatic cholangiocarcinoma who underwent hepatectomy. PMID: 23645762 Ref: Inflammation-related DNA damage and expression of CD133 and Oct3/4 in cholangiocarcinoma patients with poor prognosis. PMID: 23917144 |
Ref: miR-34 is associated with poor prognosis of patients with gallbladder cancer through regulating telomere length in tumor stem cells. PMID: 24078448 Ref: Association of genetic variants of cancer stem cell gene CD44 haplotypes with gallbladder cancer susceptibility in North Indian population. PMID: 24186075 Ref: Clinicopathologic significance of Sox2, CD44 and CD44v6 expression in intrahepatic cholangiocarcinoma. PMID: 24482053 Ref: Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo. PMID: 24725816 Ref: PCBP1 is an important mediator of TGF-beta-induced epithelial to mesenchymal transition in gall bladder cancer cell line GBC-SD. PMID: 24889597 Ref: Primary hepatic neuroendocrine carcinoma with a cholangiocellular carcinoma component in one nodule. PMID: 26184027 |
Ref: Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44nu is an indicator for recurrence in advanced cancer. PMID: 26572077 |
Ref: Association of cancer stem cell markers genetic variants with gallbladder cancer susceptibility, prognosis, and survival. PMID: 26318430 Ref: CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment. PMID: 27176078 |
Ref: Isoform switch of CD44 induces different chemotactic and tumorigenic ability in gallbladder cancer. PMID: 28677740 Ref: Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells. PMID: 28930164 Ref: Isolation and identification of tumor-initiating cell properties in human gallbladder cancer cell lines using the marker cluster of differentiation 133. PMID: 29344142 |
Ref: Tumor-associated macrophages recruited by periostin in intrahepatic cholangiocarcinoma stem cells. PMID: 29805605 |